39324867|t|Elevated serum circulating cell-free mitochondrial DNA in amyotrophic lateral sclerosis.
39324867|a|BACKGROUND AND PURPOSE: The substantial role of inflammation in amyotrophic lateral sclerosis (ALS) is gaining support from recent research. Studies indicate that circulating cell-free mitochondrial DNA (ccf-mtDNA) can activate the immune system and is associated with neurodegenerative diseases. This research was designed to quantify ccf-mtDNA levels in the serum of ALS patients. METHODS: The medical records of ALS patients were reviewed. Serum ccf-mtDNA levels of patients with ALS (n = 62) and age-matched healthy controls (n = 46) were measured and compared. Additionally, serum interleukin-6 (IL-6) levels were measured using an enzyme-linked immunosorbent assay in 26 ALS patients. Correlations between variables were analyzed. RESULTS: Serum ccf-mtDNA was notably higher in the patients with ALS. When stratified by genotype, the superoxide dismutase 1 (SOD1) mutation group showed the greatest increase in ccf-mtDNA levels relative to other ALS patients. Among all 108 individuals, a cut-off set at 1.1 x 105 mtDNA copies on a receiver-operating characteristic curve identified patients with ALS with 80.7% sensitivity and 50.0% specificity; the area under the curve was 0.69 (p < 0.001). Furthermore, serum ccf-mtDNA levels correlated negatively with the progression rate of ALS (DeltaFS; rs = -0.26, p = 0.044), but not the ALSFRS-R score (rs = 0.06, p = 0.625). Importantly, the correlation between ccf-mtDNA and DeltaFS was more pronounced in the SOD1 mutation group (rs = -0.62, p = 0.018). Lastly, a significant positive association was observed between serum ccf-mtDNA levels and IL-6 levels in ALS (r s= 0.41, p = 0.038). CONCLUSION: Our study found increased serum ccf-mtDNA in ALS patients, suggesting a link to inflammatory processes and disease mechanism. Moreover, ccf-mtDNA could be an indicator for ALS progression, especially in those with the SOD1 mutation.
39324867	58	87	amyotrophic lateral sclerosis	Disease	MESH:D000690
39324867	137	149	inflammation	Disease	MESH:D007249
39324867	153	182	amyotrophic lateral sclerosis	Disease	MESH:D000690
39324867	184	187	ALS	Disease	MESH:D000690
39324867	293	296	ccf	Gene	5307
39324867	358	384	neurodegenerative diseases	Disease	MESH:D019636
39324867	425	428	ccf	Gene	5307
39324867	458	461	ALS	Disease	MESH:D000690
39324867	462	470	patients	Species	9606
39324867	504	507	ALS	Disease	MESH:D000690
39324867	508	516	patients	Species	9606
39324867	538	541	ccf	Gene	5307
39324867	558	566	patients	Species	9606
39324867	572	575	ALS	Disease	MESH:D000690
39324867	675	688	interleukin-6	Gene	3569
39324867	690	694	IL-6	Gene	3569
39324867	766	769	ALS	Disease	MESH:D000690
39324867	770	778	patients	Species	9606
39324867	841	844	ccf	Gene	5307
39324867	877	885	patients	Species	9606
39324867	891	894	ALS	Disease	MESH:D000690
39324867	929	951	superoxide dismutase 1	Gene	6647
39324867	953	957	SOD1	Gene	6647
39324867	1006	1009	ccf	Gene	5307
39324867	1041	1044	ALS	Disease	MESH:D000690
39324867	1045	1053	patients	Species	9606
39324867	1178	1186	patients	Species	9606
39324867	1192	1195	ALS	Disease	MESH:D000690
39324867	1308	1311	ccf	Gene	5307
39324867	1376	1379	ALS	Disease	MESH:D000690
39324867	1502	1505	ccf	Gene	5307
39324867	1551	1555	SOD1	Gene	6647
39324867	1666	1669	ccf	Gene	5307
39324867	1687	1691	IL-6	Gene	3569
39324867	1702	1705	ALS	Disease	MESH:D000690
39324867	1774	1777	ccf	Gene	5307
39324867	1787	1790	ALS	Disease	MESH:D000690
39324867	1791	1799	patients	Species	9606
39324867	1822	1834	inflammatory	Disease	MESH:D007249
39324867	1878	1881	ccf	Gene	5307
39324867	1914	1917	ALS	Disease	MESH:D000690
39324867	1960	1964	SOD1	Gene	6647
39324867	Positive_Correlation	MESH:D000690	5307
39324867	Association	MESH:D000690	6647
39324867	Association	5307	6647

